iShares S&P Software Index Fund (NY:IGV)
104.25
+1.17
(+1.13%)
Streaming Delayed Price
Updated: 9:39 AM EDT, Aug 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 433,422 |
| Open | 103.85 |
| Bid (Size) | 104.23 (200) |
| Ask (Size) | 104.24 (800) |
| Prev. Close | 103.08 |
| Today's Range | 103.55 - 104.41 |
| 52wk Range | 73.93 - 117.99 |
| Shares Outstanding | 1,080,000 |
| Dividend Yield | 0.02% |
Top News
More News
Performance
More News
Read More
Why ServiceNow Stock Was Slipping Today ↗
July 22, 2026
Best 3 Tech ETF Picks for the 2nd Half of 2026 ↗
July 10, 2026
AppLovin Pulled Back 16% in June. Is It a Buy? ↗
July 08, 2026
Will AI Destroy the Software Industry? ↗
April 15, 2026
Why Markets Are Shrugging Off Trump's Hormuz Blockade ↗
April 13, 2026
Frequently Asked Questions
Is iShares S&P Software Index Fund publicly traded?
Yes, iShares S&P Software Index Fund is publicly traded.
What exchange does iShares S&P Software Index Fund trade on?
iShares S&P Software Index Fund trades on the New York Stock Exchange
What is the ticker symbol for iShares S&P Software Index Fund?
The ticker symbol for iShares S&P Software Index Fund is IGV on the New York Stock Exchange
What is the current price of iShares S&P Software Index Fund?
The current price of iShares S&P Software Index Fund is 104.25
When was iShares S&P Software Index Fund last traded?
The last trade of iShares S&P Software Index Fund was at 08/13/26 09:39 AM ET
What is the market capitalization of iShares S&P Software Index Fund?
The market capitalization of iShares S&P Software Index Fund is 112.58M
How many shares of iShares S&P Software Index Fund are outstanding?
iShares S&P Software Index Fund has 113M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.